Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells by unknown
Evidence that soluble factors are important in T cell mitogenesis began with
experiments in which leukocyte-conditioned media enhanced growth in the
presence of lectin (1, 2) . Two factors were identified in these media (3) : IL-1, a
macrophage product originally termed lymphocyte activating factor and IL-2, a
T cell product originally termed T cell growth factor . A longstanding hypothesis
has been that T cells proliferate when exposed to antigen (or polyclonal stimuli
like lectins) plus IL-1, with both signals originating from accessory or antigen-
presenting cells (4) . It has been further proposed that IL-1 acts directly on T
cells either to induce IL-2 release (5, 6) or responsiveness (7) . Much of the
supporting evidence for these ideas has derived from selected T cell lines and
leukemias (7, 11), subpopulations of thymocytes (5, 12), or from primary T cell
populations that may not have been rigorously depleted of accessory cells (5, 6) .
Recent advances have made it possible to analyze the function of IL-1 on
primary lymphocytes . A purified recombinant IL-I (rIL-1) has been produced
that has the same biologic activity as macrophage-derived IL-I (13) . The cells
involved in T-dependent responses also are better characterized. These include :
dendritic cells (DC),' which are the principal accessory cells for the growth of
resting helper lymphocytes (14-17) ; primed antigen-specific T lymphoblasts,
which actively release and respond to IL-2 (18) ; and memory T cells, which are
derived from the blasts butare no longer IL-2 responsive (19) .Wehaveexamined
the effects of rIL-I on DC and onT lymphocytes in different states ofactivation .
We find that IL-1 has little direct effect on peripheral T cells and does not
synergize with antigen to initiate T-dependent responses . Instead, the amplifying
role of IL-I is due to an effect on the accessory function of DC, which increases
substantially after exposure to IL-1 but not to other cytokines .
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Materials and Methods
6-10-wk-old mice of both sexes were obtained from the Trudeau Institute, Saranac
Lake, NY [B6.H-2k; (C x D2)F, ; C3H/Hej; (C57BL/6 x DBA/2)] and the Rockefeller
University (BALB/c/AnN ; NCS) .
' Abbreviations used in this paper:
￿
DC, dendritic cell ; EA, antibody-coated erythrocytes; TNF,
tumor necrosis factor .
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Cytokines
IL-1.
￿
Murine rIL-1 a was generously provided by Dr. P. LoMedico, Hoffman LaRoche,
Nutley, NJ . The IL-1 was purified from E. coli expressing the pIL-1 (1-156) plasmid (13)
and had a specific activity of 6 X 106 U/mg in the standard mitogenesis assay, in which
thymus cell suspensions are stimulated with PHA and IL-1 (5). IL-1 was stored at 2 X 106
or 0.4 X 106 U/ml, and was used at final concentrations of 0.005-150 U/ml. A control
preparation at 0.4 mg/ml was obtained from E. coli lacking the IL-1 cDNA insert. The
D10 G4.1 T cell clone (7) (provided by Dr. C. Janeway, Yale Univ., New Haven, CT) was
used as a more sensitive indicator for IL-I . Whereas half-maximal thymocyte costimulation
was achieved with 1-5 U/ml rIL-1, half-maximal D10 mitogenesis occurred at 0.01-0 .1
U/ml (0.1-1 .0 pM). The D10 cells were propagated in culture by stimulating 106 cells
with 5 X 106 irradiated (6,000 rad's'Cs) B6.H-2k spleen cells and 100 rug/ml conalbumin
(Sigma Chemical Co., St. Louis, MO) in 10 ml medium in 100-mm culture dishes. Four
or more days later, the D10 cells were isolated on Histopaque (Sigma Chemical Co. ;
specific gravity of 1 .119) columns (two or three Petri dishes of cells on 20 ml, 500 g for
20 min at room temperature). Viable cells at the interface were cultured overnight before
use in the bioassay. 2-3 X 109 D10 were plated in flat-bottomed microtest wells (Costar,
Cambridge, MA) with serial dilutions of IL-1 or viable DC in a total volume of 0.1 ml for
3 d. Proliferation was assessed after culture in 0.5 uCi[SH]TdR (Schwartz Mann, Orange-
burg, NY; 6.7 Ci/mM) for 16 h on day 2-3 . D10 cells did not require the addition of Con
A to respond to IL-1 and also did not respond to LPS.
rIL-2.
￿
Human rIL-2 at 8.5 X 105 U/mg was provided by Biogen Corp., Cambridge,
MA. IL-2 activity in subsaturating volumes of medium was measured using Con A-
stimulated lymphoblasts as responders. 5 X 106 lymph node cells in 5 ml medium were
stimulated for 3 d with I ug/ml Con A (Pharmacia Fine Chemicals, Uppsala, Sweden). 2
X 104 washed lymphoblasts were then cultured with graded doses of IL-2 for 24 h, and
proliferation was measured with a 4-6 h pulse of 1 .75 ACi [sH]TdR. Human IL-2 gave
half-maximal stimulation of mouse Con A blasts and the D10 line at 3-10 U/ml .
rIFN-y. Murine rIFN-y at 6 X 106 U/mg was provided by Genentech, South San
Francisco, CA. 1 U/ml for 48-h optimally activated mouse peritoneal macrophages to
release H202 (20) and to express la antigens (21,,22). To induce la, we cultured elicited
(1 ml Brewers' thioglycollate ; Difco, Detroit, MI) peritoneal macrophages (0.7-7 X 104
cells per 12-mm circular glass coverslips; Propper Mfg. Co., Long Island, NY) for 3 d,
with or without IFN-y at 10 U/ml. Elicited but not resident peritoneal cells responded to
IFN-y as described (22). Induction of la antigens was visualized by staining cells with
hybridoma culture supernatants (American Type Culture Collection, Bethesda, MD): 10-
2.16 anti-la' (TIB 93) followed by FITC-goat anti-mouse Ig, B21-2 anti-lad followed by
FITC-mouse anti-rat Ig, or biotin, 14-4-4S anti-I-E"' (HB 32) followed by FITC-avidin.
Staining was monitored by immunofluorescence microscopy and judged to be specific
through the use of an isotype-matched control mAb or with cells from the inappropriate
haplotype (22).
Recombinant cachectin/tumor necrosisfactor (TNF).
￿
Human recombinant cachectin was
synthesized in a yeast expression system by Chiron, Emeryville, CA. Recombinant cach-
ectin was purified and provided by Dr. B. Beutler, the Rockefeller University. The specific
activity was 108 U/mg in the L929 cytolysis assay (23) and had 0.4 ug/mg LPS activity in
the limulus amebocyte assay.
Conditioned media.
￿
Several media were used as natural sources of cytokines, as estab-
lished in the above bioassays and in an assay for IL-3 (24). The media were from the J774
macrophage cell line stimulated with LPS (IL-1 and TNF); WEHI-3 cell line (IL-3);
keratinocytes from murine epidermis (25), which release activities similar if not identical
to IL-I and IL-3 (26, 27). rIL-2, recombinant cachectin, and WEHI-conditioned media
did not induce the release of I L-1 (D10 bioassay) from spleen macrophages, which indicates
that these preparations had < 1 ng/ml LPS .
Culture medium.
￿
RPMI-1640 (Gibco, Grand Island, NY) was supplemented with 10%
heat-inactivated FCS (Hyclone, Logan, UT), 1 mM glutamine (KC Biologicals, Inc.,Lexena, KS), 100 jug/ml streptomycin and 100 U/ml penicillin (Gibco), 20 kg/ml genta-
mycin (Gibco) and 5 X 10-5M 2-ME .
T Cells and T Cell Proliferation
Unprimed peripheral T cells .
￿
Unprimed peripheral T cells were nylon wool-nonadher-
ent, spleen, and lymph node suspensions that were treated with anti-la mAb (10-2.16 anti-
I-A° or B21-2 anti-I-Ad) and pooled rabbit complement (Pel-Freeze, Brown Deer, WI) to
deplete residual B cells and DC. In some experiments (see Results), anti-Lyt-2.2 mAb
(TIB 150, American Type Culture Collection) was used to deplete the cytolytic T cell
subset, and Jlld (TIB 183, American Type Culture Collection) to further deplete
accessory cells. J11 d kills purified DC and reduces the residual Con A responsiveness of
anti-la and complement-treated, nylon-nonadherent cells. T cell proliferation was fol-
lowed in the syngeneic and allogeneic MLR, and the polyclonal response to 1 wg/ml Con
A or 1 .2 mM sodium periodate (14-16). In each, graded doses of accessory cells were
added to 3 X 105 responder T cells in 0.2 ml medium in flat-bottomed 96-well plates, or
3 X 106 T cells in 2 ml medium with 24-well plates . 1 y.Ci ['H]TdR in 50 I1 medium was
added for 16 h at the times indicated in the Results. Data are means oftriplicates in which
standard deviation ranged from 5-20% of the mean . All experiments were repeated at
least once .
Freshly sensitized T lymphoblasts .
￿
Freshly sensitized T lymphoblasts were induced by
allogeneic DC as described (18) . The blasts doubled (t,,. of 14-16 h) in response to IL-2 .
Memory Tcells.
￿
Memory T cells were prepared by resting the blasts for three or more
days in the absence of exogenous IL-2 or alloantigen (19) . The blasts and memory
populations were >70% allospecific, as assessed in rapid DC-T binding assays (28) .
Proliferative responses were measured with 1 .75 ACi ['H]TdR applied for 6-8 h at the
indicated times .
PrimaryAntibody Responses
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Mixtures of accessory-cell depleted B and T lymphocytes were obtained by passing
spleen suspensions over Sephadex G10 (17) . 4 X 10 lymphocytes were cultured in 16-
mm-diam wells for 4 d with antigen (2 X 106 SRBC ; or 10,ug/ml TNP-KLH) and graded
doses of DC (17) . PFC were measured on both SRBC and TNP-SRBC to establish the
antigen specificity of the PFC response .
Accessory Cells
Low-density spleen adherent cells were separated into DC- and macrophage-rich com-
ponents by rosetting with antibody-coated erythrocytes (EA) (29) . The EA-, DC-enriched
populations were>90% DC .TheEA' fraction had roughly equal numbers ofmacrophages
and B cells and a small (3-10%) percentage of DC . DC were identified on the basis of
irregular cell shape, and absence of Fc receptors, and macrophage/lymphocyte surface
markers (29) . The level of DC Ia was monitored on a FAGS IV (Becton Dickinson
Immunocytometry Systems, Mountain View, CA) after staining with FITC-1121-2 anti-
Ia . To inactivate the accessory function of DC, we exposed the cells to a UV lamp (General
Electric, 15 W ; G15T8) for 2-4 min at a distance of 10 cm . Ia' and Ia- macrophages
were obtained by culturing thioglycollate-elicited peritoneal cells for 3 d with and without
rIFN-'Y as described above . The macrophages were cultured in graded doses on 12-mm
coverslips, or the exudates were maintained in suspension in Teflon beakers (32) and
harvested 3 d later. 1 ug/ml indomethacin was added to all T cell responses in which
macrophages were used as accessory cells.
Dendritic-TCell Clustering
To follow the clustering of DC with T cells during the MLR, we labeled the DC with
a nontoxic, stable, carbocyanine dye (30) . We applied 1,1'-dioctadecyl-3,3,3',3'-tetra-
methylindocarbocyanine perchlorate (diI) (Molecular Probes, Junction City, OR) at 20
jug/ml to purified DC for 1 h at 37°C . This treatment did not alter the stimulatory
function of DC, which clustered with helper T cells early in the MLR as described (18) .51 8
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TABLE I
Effects ofrIL-1 and rIL-2 on T Cell Proliferation and IL-2 Release: Comparison with DC
The numbers and culture intervals for the different T cells were: 3 X 105 unprimed pulsed at 72-
78 h; 3 X 104 primed blasts pulsed at 26-36 h ; 3 X 104 memory cells pulsed at 72-78 h . Before
adding 1 uCi ['H]TdR to measure T cell proliferation, 50,ul of medium was removed for the IL-2
bioassay on 3 X 104 Con A blasts in 100 jul final volume . The latter values for IL-2 in the medium
represent II-2 release in most cultures . When rIL-2 was added to wells without cells, the level of
activity was30,000 cpm, so that there appeared to be no endogenous IL-2 release in cultures exposed
to exogenous IL-2 .
One could therefore count the number of DC in the cluster and noncluster fractions and
monitor the effect of IL-1 on clustering and on subsequent mitogenesis (see Results) . 1 .5-
5 X 10 9 dye labeled DC were cultured with 5 X 106 CD4+ cells in 16-mm macrowells for
1 d, and the DC-T aggregates were isolated by velocity sedimentation (18) . Aliquots of
the clusters were dissociated with gentle pipetting and fixed in 3.7% formaldehyde/PBS .
The frequency of fluorescent dye labeled cells was measured in a hemocytometer . The
bulk of the clustered cells were returned to culture to assess the mitogenesis that ensued
in the presence ofknown numbers ofDC . As will be evident in the Results, all proliferating
T cells in the MLR cluster with DC within 24 h of coculture .
Results
IL-1 Has No Direct Effect on Unprimed andSensitized TLymphocytes .
￿
T lympho-
cytes in three physiologic states ; unprimed cells, freshly sensitized IL-2-responsive
blasts, and memory cells were cultured with IL-1, IL-2, IL-1 and IL-2, or DC .
IL-1 did not induce either proliferation or IL-2 release, and IL-1 did not
synergize with IL-2 (Table I) . The IL-1-rich conditioned media of macrophages
and keratinocytes (not shown) also had no effect on any of the T cell populations .
IL-2 induced significant proliferation only in the T blasts, but no IL-2 release .
Stimulus applied to T
cells
Proliferative response
Unprimed
Response (cpm X
Primed blasts
10-') of Lyt-2-T
3-d memory
cells
7-d memory
None 0.2 1 .1 0.3 0.3
10 4 DC 26 .1 60.8 282 .1 210.1
10' DC 2.0 39.5 179.8 133.3
10 2 DC 0.5 14.8 52 .9 44.7
rIL-2, 125 U/ml 0.6 42.7 8.8 3.7
rIL-1, 25 U/ml 0 .4 1 .0 0 .7 0.4
rIL-2+rIL-1 1 .4 57.3 9.1 12 .1
IL-2 in medium
None 0.4 1 .2 0.5 0.5
10 4 DC 19.0 48.6 40.2 50.4
10' DC 1 .7 14.8 16 .3 44.4
10 2 DC 0.7 2.7 5.1 15.6
rIL-2, 125 U/ml 30.6 7.8 9 .0 27.5
rIL-1, 25 U/ml 0.5 1 .3 0.6 0.5
rIL-2 + rIL-1 29.0 ND 6.2 13.6TABLE 11
rIL-1 Does Not Sustain theIL-2 Responsiveness ofHelper (Lyt-2) TBlasts
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3 X 105 alloreactive (C X D2 anti-B6,H-2k) Lyt-2' T blasts were rested in macroculture with or
without 50 U/ml rIL-1 for 2 d. 3 X 10'T cell aliquots were then transferred, with or without IL-1
into microtest cultures with graded doses of rIL-2. Proliferation and IL-2 in the medium was then
assayed (cpm X 10' as in Table I) at 18 and 42 h(day 1/2) .
DC, in contrast, stimulated growth and lymphokine production in all T cell
populations (Table I) .
To test whether IL-1 could sustain rather than induce IL-2 responsivess, we
cultured IL-2-responsive T blasts for 2 d with or without IL-1, and then added
IL-2 . Even in the presence of IL-l, the T blasts lost the capacity to respond to
IL-2, but not to DC (Table II) .
Lack of Synergism between IL-1 and Antigen or Lectin in Primary Responses.
￿
A
long-standing hypothesis states that IL-1 acts in concert with antigen to activate
resting lymphocytes . We tested this hypothesis in the primary MLR, where class
II MHC products (Ia glycoproteins) carry the antigens recognized by allogeneic
CD4 (Lyt-2-) T cells . The experiment was made possible by the fact that
peritoneal macrophages can be induced to express I-A and I-E products with
IFN- .y . Expression of la was evident on most macrophages by immunofluores-
cence microscopy (Fig . 1) and by FACS analysis (not shown) . These Ia+ popula-
tions induced little or no MLR even in the presence of exogenous IL-1 (Fig . 2) .
Two other populations of Ia+ cells, Sephadex G10-nonadherent spleen B cells
(17) and UV-inactivated DC were also nonstimulatory, with or without IL-1 (not
shown) . Therefore, la antigens on DC activate unprimed allogeneic T cells,
whereas alloantigens on other cells are not stimulatory even in the presence of
exogenous IL-1 .
We next evaluated whether IL-1 could synergize with polyclonal T cell
mitogens . Nylon wool-nonadherent peripheralT cells were treated with anti-Ia
and J 11 d mAb to diminish the level of residual non-T cells that could provide
accessory function . The T cells were then cultured with 1 ug/ml Con A,
exogenous IL-1, and/or accessory cells . The response to mitogen + rIL-1 was
minimal, and consistently <5% of a low dose of accessory DC (10' DC per 3 X
105 T cells ; Table III) . Similar results were obtained whenT cells were modified
with another mitogen, sodium periodate (not shown) .
IL-1 Amplifies DC-mediated Responses.
￿
Exogenous IL-1 did amplify the MLR
if DC were the source of alloantigen and if IL-1 was added at the onset of culture
(Table IV) . IL-1 had little or no effect when added at 24 h, or at later times .
The amplification of the proliferative response, or the shift in the dose/response
curve, varied from 3- to 10-fold . 5 U/ml IL-1 (50 pM) gave maximal amplifica-
tion, whereas 0 .5 U/ml was less than half maximal (not shown) .
The effect of IL-1 on DC function was tested in other T cell proliferative
Growth (day 1/2) IL-2 in medium (day 1/2)
T cells
No rIL-2 500 U/ml rIL-2 No rIL-2 500 U/ml rIL-2
Blasts, rested 2 d, + IL-1 0.2/0.2 0.4/1 .3 0.5/0.4 33 .9/33 .8
Blasts, rested 2 d, no IL-1 0.2/0 .3 0.2/1 .0 0.3/0.4 36.6/39.8
Freshly prepared lymphoblasts 0.7/0.3 54.1/56.6 0.5/0.3 22.6/14.2520
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FIGURE 1 . Expression of la on cultured macrophages . Thioglycollate-elicited, peritoneal
cells (>80% macrophages) were cultured with (top) or without (bottom) IFN-'Y for 3 d . The
cells were maintained as monolayers for3 d, or in suspension in beakers (32) . Shown here are
cells from H-2d mice . Themicrographs on the left side ofthe figure werestained (see Materials
and Methods) with rat B21-2 anti-I-Adand L3T4 (anti-CD4) as the ratIgG2b isotype control .
On the right are stains with mouse 14-4-4S anti-I-E', and 10-2 .16 anti-I-A' as the haplotype
and IgG2a isotype control . Note the induction ofboth I-Aand I-E antigens with IFN--y (phase-
contrast micrographs are not shown, but >70% of the cells were Ia+) in contrast to the low
(<3%) frequency of Ia+ cells in the steady state . Reciprocal results were obtained with B6.H-
2k cells in that 10-2.16 stained most of the cells cultured in IFN-,y, while B21-2 did not.
responses. Comparable effects were seen in the syngeneic and allogeneic MLR,
and in Con A- and periodate-mediated mitogenesis (not shown) . The primary
antibody response to T-dependent antigens is another model in which DC are
active if not essential accessory cells. Addition of rIL-1 increased the efficacy of
DC (PFC response per DC) -I 0-fold (Table V) . In all cases, antibody formation
was antigen-dependent and specific (Table V).
IL-1 Acts on DC Rather than T Cells to Amplify Responses.
￿
We then compared
the effects of exogenous IL-1 during the MLR, with prior treatment of the
allogeneic DC . Spleen adherent cells were cultured overnight (16 h) with or
without 50 U/ml exogenous rIL-1 . The cells were washed three times and
separated into Fc receptor-negative (EA- , DC-enriched) and Fc receptor-posi-
tive (EA+; 40-50% each, macrophages and B cells, and <10% DC) for use as
stimulators of T cell proliferation . The EA+ fraction, which usually is contami-
nated with 5-10% DC (29), was <10% as active as the EA- fraction . Prior
treatment with IL-1 enhanced stimulatory activity especially of theEA- fractions.. 1os
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￿
IL-1 does not synergize with antigen to activate T cells . Thioglycollate-elicited
peritoneal macrophages were cultured with or without IFN--y to yield populations that were
>70% I-A' and I-E+ macrophages (Fig . 1) . On the left areB6.H-2k cells cultured as monolayers
on coverslips without (Ia) or with (la') IFN-y . 3 X 106 allogeneic [(C X D2)F I, H-2d] Lyt-2-
T cells were added to the coverslips in 16-mm wells, with or without exogenous rIL-I at 50
U/ml . On the right are(C X D2)Fl peritoneal cells that were cultured in suspension (32) with
or without IFN-y and then added to microtest wells with 3 X 10 5 Ia , Lyt-2" B6.H-2k T cells,
with or without IL-1 . At 80-96 h, the cultures were pulsed with ['H]TdR to assess the extent
of the MLR. Simultaneous experiments showed that the macrophages inhibited the DC-
induced MLR 30-70% at the stimulator doses that were used,and that the macrophages were
producing little or no endogenous IL-1 (Koide, manuscript in preparation) .
TABLE III
Lack ofSynergism between Con A and IL-1 in theAbsence ofAccessory Cells
52 1
Nylon wool-nonadherent spleen and lymph node lymphocytes were treated with a combination of
hybridoma culture supernatants to eliminate Lyt-2+ cells (TIB 150, anti-Lyt-2) and non-T cells (1321-
2 anti-la andjI Id anti-non-T cell) . 3 X 10 5 purified T cells were cultured in flat microtest wells
with Con A, IL-1, and accessory cells as indicated . DC were EA- low-density spleen adherent cells .
Macrophages were 2-h adherent, thioglycollate-elicited peritoneal cells. In the same experiment (not
shown), we tested populations of 3-d cultured adherent peritoneal cells (with or without IFN-y), but
these were even less active (104 cpm with 3 X 10' macrophages and 2.5 X 10' cpm with 3 X 10'
macrophages) than the fresh peritoneal adherent cells .
(Fig . 3) . PulsingDC with IL-1 was as effective as adding IL-1 continuously, and
in most experiments (13 of 18) more effective (Fig . 3) . The dose of IL-1 that
was required to maximally enhance DC function was 5 U/ml (50 pM), and the
enhancement increased progressively with exposure time, reaching a plateau at
18-24 h with no furtherincrease after48 and 72 h (not shown) . Ifthe responding
Additions Proliferative response (cpm X 10-' ['H]TdR) of-
1 ag/ml 50 U/ml T cells T cells + DC T cells + macrophages
Con A IL-1 only 30 300 3,000 300 3,000 30,000
- - 0.2 0.3 0.3 1 .0 0.3 0.2 2.0
- + 0.3 0.3 0.5 0.8 0 .3 0.8 2.0
+ - 0.4 1 .8 18.3 129 1 .1 8.7 26.2
+ + 2.1 5.6 40.5 184 3.0 23.8 45.4522
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TABLE IV
IL-1 Enhances TCell Proliferative Responses to DC When Added Early in the MLR
Graded doses of H-2d DC were added to purified H-2kT cells (3 X 10 5). IL-1 was omitted from the
cultures or added at 50 U/ml at the indicated times. Data are means of triplicates ± SD for MLRs at
72-90 h . T cells only gave 1 .2 x 10 9 cpm uptake .
TABLE V
Effects ofrIL-1 and DC on Primary T-dependent Antibody Responses
Macrocultures (1 ml medium 5% FCS in RPMI 1640 with 5 x 10-5 M 2-ME ; 16-mm-diam wells)
were set up with the indicated numbers of B/T (Sephadex G10-nonadherent spleen), B (G10-
nonadherent treated with anti-Lyt-1, anti-Thy-1, and complement), and DC (low-density spleen
adherent cells depleted of macrophages by readherence to plastic) . The antigens were none, 5,ug/ml
TNP-KLH, or 2 x 106 SRBC. After 4 d, plaque assays were run on TNP-SRC or SRBC indicator
cells .
T cells were pulsed with IL-1 or if allogeneic la' macrophages were pulsed,
there was no enhancement of the subsequent MLR (not shown) .
Other Cytokines Do Not Enhance the Accessory Function ofDC .
￿
Several recom-
binant cytokines and two conditioned media that were rich in natural IL-1 were
added to DC for 18 h. The cells were washed, and the EA- DC were used as
stimulators of T cell mitogenesis . Only the exposure to IL-1, but not to other
lymphokines further enhanced DC function for all four T cell proliferative
Exp . Cells
No
antigen
Antibody response (anti-TNP/anti-SRC PFC) with:
No IL-I, and : 50 U/ml IL-1, and :
TNP-KLH SRC No antigen TNP-KLH SRC
1 4 x 106 B/T 0/4 0/4 8/0 4/0 4/0 0/8
B/T + 3 x 104 DC 4/0 1,116/144 16/716 12/8 1,360/260 132/1,008
B/T+ 10 4 DC 12/4 980/32 20/544 12/8 1,616/300 76/992
B/T + 3 x 109 DC 12/4 504/20 4/432 8/4 1,408/256 92/784
B/T + 10 9 DC 4/0 352/4 0/188 4/4 1,024/200 68/500
B/T + 3 x 102 DC 0/8 76/0 0/84 8/4 652/84 32/348
B/T + 10 2 DC 4/0 16/0 0/28 8/0 348/16 4/220
2 4 x 106 B/T 0/0 20/0 0/0 8/12 140/24 20/16
2 x 10 6 B NT NT NT 4/0 28/12 0/0
B+ 10 4 DC NT NT NT 0/0 16/8 4/0
B/T + 3 X 104 DC 20/4 1,540/128 20/916 NT NT NT
B/T + 10 4 DC 4/0 1,032/132 0/456 56/40 1,352/108 4/716
B/T + 3 x 109 DC 0/4 800/96 12/204 12/0 1,188/124 4/584
B/T + 10 9 DC 0/0 500/68 20/56 28/0 1,092/112 4/428
Time of IL-1
addition
Proliferative
10,000
response (cpm x
3,000
10'9 [9H]TdR) to graded
1,000
doses DC
300
Day 0 77.0±6.0 40.7±7.9 21.6±3 .7 16.9±5.4
Day 1 39.2±4.6 14.2±2.9 10.0±1.5 5.9±0.8
Day 2 45.1±7.7 16.2±3.9 6.2±2 .5 1.2±0.4
Day 3 35.4±1 .1 10.4±2.6 4.6±1.4 1.7±0.3
No IL-1 37.4 ± 4.1 8.9 ± 2.5 2 .4 ± 0.7 2.4 ± 0.9105
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FIGURE 3 .
￿
Effect of rIL-1 on DC function in the MLR. Low-density spleen adherent cells
were cultured overnight with or without 50 U/ml IL-1, washed, and separated into EA- and
EA' fractions. The cells were added in graded doses to 3 x 10 5 allogeneic T cells with or
without additional exogenous IL-1, as indicated . The MLR was measured at 72-90 h . Note
that DC that were pulsed with IL-1 were some 3-10 times more effective .
3x102 103 3IA03 106 3x10 103 3.103 106 102 3x10 103 3x10 3x10' 103
Number of DC / culture
523
3003 106
FIGURE 4 .
￿
Effect of IL-1 on DC function inT cell mitogenesis. Low-density spleen adherent
cells were cultured overnight in the presence ofrecombinant cytokines .The cells were washed,
andEA-DC were prepared and added to purifiedT cells in four different proliferative assays .
In all cases, pulsing the DC with IL-1 enhanced function while pulsing with IFN-'Y decreased
function .
Adherent
cells
Treatment
with IL-t
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TABLE VI
Pulsing with IL-1, But Not with Other Cytokines, Enhances the Accessory Function ofDC
n
15
3 x 10' la-, Lyt-2- T cells were stimulated with graded doses ofallogeneic DC (MLR)-or syngeneic DC (Con A) that had been pulsed
overnight with the indicated cytokines. The data are proliferative responses ± SD. IL-1 activities (DIO assay) forthe keratinocyte- and
macrophage-conditioned media were 5 and 10 U/ml respectively . T cell only responses were 748 and 5,671 cpm for the MLR and
lectin responses .
Doseof RIL1/culture ( U/ml )
.0005 .005 .05 .5 5 50
3x102 103 3.10' 104 10 3 3x10 3 104 3x10 4
Number of DC/culture
￿
Number of DC Iculture
FIGURE 5 .
￿
Effects of IL-1-pulsed DC on the MLR and the D10 cell line . DC were cultured
overnight in the indicated doses of IL-1 and then added in graded doses to allogeneic CD4+
T cells (left) or to the IL-1-responsive D10 cell line (right). The effects of graded doses of rIL-
1 on the cell line are shown (filled circles) . Note that a dose of 1 U/ml is required to detect an
increase in DC function in the MLR, but that DC exhibit little or no IL-1 activity in the D10
bioassay .
responses (Fig . 4) . The effects of macrophage and keratinocyte culture media
were similar to rIL-1 (Table VI) . IL-2, IL-3, and cachectin/TNF had little effect,
while exposure to IFN-y decreased DC function in both experiments (Fig. 4,
Table VI).
Studies on Mechanism ofAction ofIL-1 on DC .
￿
To test whether IL-1-pulsed DC
were simply carrying over this cytokine into the subsequent culture, we added
DC that had been exposed to graded doses of IL-1 to the MLR and D10 assays .
Exposure of DC to 1 U/ml IL-1 produced a detectable increase in DC function
in the MLR, while 10 U/ml gave a maximal effect (Fig . 5, left) . However, DC
that had been pulsed with 0-100 U/ml IL-1 had comparable but weak IL-1
activity in the sensitive D10 bioassay (Fig . 5, right) . The activity of DC at the
highest dose used for accessory function (30,000 DC) corresponded to 0.01
U/ml of exogenous IL-1, yet I U/ml was the minimal continuous dose needed
Proliferative response (cpm x 10-s [sH]TdR) to graded doses ofDC
Cytokine/dose
10,000
MLR (day 3-4)
3,000 1,000 1,000
Con A (day 2-3)
300 100
None 71 .9±11 .7 15.8±3.3 2.7±0 .8 71.7±8 .0 28.630 .9 11.5±1 .5
rIL-1, 50 U/ml 150 .4 ± 5 .6 47 .0 ± 1 .6 9.7 ± 0 .7 130 .6 ± 13 .4 68 .7 ± 0 .4 35 .8 ± 3 .8
30% Keratinocyte supernatant 142 .5 ± 11 .3 38 .3 ± 2.0 7 .9 ± 1 .4 134 .2 ± 2 .7 64 .4 ± 3 .4 33 .1 ± 2 .6
30%, Macrophage supernatant 152 .2 ± 11 .6 42 .8 ± 6.9 8.0 ± 1 .5 148 .2 ± 10 .2 69.2 ± 6 .0 29 .4 ± 1 .3
rIL-2, 1000/ml 102.1±8.2 18.0±1 .5 5.230 .7 95.3±6 .9 37.7±2 .6 14.9±1 .2
30% WEHI-3 supernatant 104 .2 ± 2.7 21 .7 ± 5.1 3.6 ± 0 .2 94 .3 ± 7 .1 39.6 ± 1 .0 17 .2 ± 2 .2
rIFN-7, 100U/ml 15.0±1 .6 2.1±0.3 0.4±0 42.6±2 .6 14.8±2.5 7.3±1 .2
rTNF,1ng/ml 86.4±7 .3 17.2±2 .1 2.7±0 .6 94.9±4 .1 40.932.6 15.1±2 .8KOIDE ET AL .
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FIGURE 6.
￿
Studies of the effects of IL-1 on DC . (A) Effect of IL-1 on expression of la
antigens. After 18 hof culture with or without50 U/ml ofAL-1, DC were exposed to FITC-
B21-2 (thick line), or FITC-goatanti-mouse Ig (thin line), or FITC-9.3 (anti-human Ia ; dashed
line) and analyzed on the FACS . Note that the level of la on DC was not changed by IL-1 .
The amount of la on DC was about twice that observed on macrophages exposed to IFN-'y,
as was previously documented using binding of "I-1321-2 (22) . (B) Carbocyanine-dye labeling
of DC . Carbocyanine dyes are stable nontoxic labels that permit the enumeration of DC in
long-term culture . Shown are two DC immediately after labeling with 20 tcg/ml dil and
observed under the hemocytometer by phase contrast (top) or fluorescence (bottom) . The
labeling consists of a diffuse fluorescence as well as anumber of bright cytoplasmic granules .
(C) Movement of dye-labeled DC into T cell clusters. DC, labeled as in B, were added to
allogeneic CD4 cells for 1 d. Cluster (shown here)and noncluster fractions were isolated and
the fluorescent DC (two labeled cells, shown by arrow) counted on a hemocytometer (see
Table VII for data) .
to see an enhancing effect in the MLR. Also, the MLR-stimulating activity of
300 DC was clearly enhanced by prior exposure to IL-I (Fig . 5, left), but this
dose ofDC had little or no effect in the IL-1 bioassay . In other experiments (not
shown), IL-1-pulsed DC were UV irradiated to ablate accessory function, and
were added to control DC . No amplification of DC function was observed (not
shown) . We conclude that the enhanced activity of IL-1-pulsed DC is not the
result of carryover of IL-1 on or with DC . Instead, exposure to IL-1 enhances
subsequent DC function .
When exogenous IL-1 was added as a pulse or continuously to DC, viable cell
recovery was not altered if examined at daily intervals for 72 h . Expression of
cell surface la was not changed (Fig . 6) . However, IL-1-pulsed DC clustered
more effectively with T cells in the MLR, and this enhanced clustering was
sufficient to account for the increase in accessory function (Table VII) . To obtain526
￿
INTERLEUKIN 1 ENHANCES DENDRITIC CELL FUNCTION
TABLE VII
IL-1-treatedDC ClusterMore Efficiently with Allogeneic CD4' TLymphocytes
* DC were cultured for 18 h with or without 50 U/ml rIL-1 and then labeled with 20 Ag/ml
carbocyanine dye . The DC were then added to 5 X 10 8 CD4* (Lyt-2-) T cells for 24 h.
$At 24 h oftheMLR, clusteredandnonclustered fractions were separatedby velocity sedimentation,
and aliquots were counted in a hemocytometer for total cells and dye-labeled DC . Specific activity
means percent DC in that fraction ; recovery means percentage of total DC that were recovered
from the velocity gradient in that fraction . The yields of DC and T cells from the columns
corresponded to 50% of the cells that were added initially to the culture. The yield of clustered
cellswas identical in all cultures and corresponded to 5-10%of the cells recoveredfrom the Percoll
gradient .
¢ Isolated clustered and nonclustered fractions were returned to culture to follow cell proliferation
in the presence of known numbers of DC. Data are means of triplicates pulsed on day 3 . The
cultures contained 3 X 10" clustered cells, 2 X 10' nonclustered cells, or mixtures thereof. In Exp .
2, we also monitored proliferation at 26-34 h, i.e ., just after isolation of the clusters. The values
were 1.3-9.8 X 10' for clusters and 0.4-1.8 X 10' for nonclusters, indicating that DNA synthesis
was just beginning at the time we measured the number of clusteredDC .
this information, we labeled the DC with a carbocyanine dye, which provided a
stable, nontoxic, fluorescent probe (31 and Fig . 6, middle). Movement of labeled
DC into DC-T cell clusters could then be monitored by fluorescence microscopy
(Fig . 6 right) and was found to be directly proportional to DC dose (Table VII) .
IL-1 pretreatment enhanced the number of clusteredDC but notT cells (Table
VII) . When mitogenesis was monitored by ['H]TdR uptake, the T cells prolif-
erated in accordance with DC numbers(regression coefficientof 0.98; not shown)
whether or not the DC had been cultured with IL-1 (Table VII) . We conclude
that IL-1 enhances the capacity of DC to cluster responsive T cells before the
onset ofDNA synthesis, but that IL-1 probably does not change the function of
DC orT cells once clustering has occurred .
Discussion
DC are active if not essential accessory cells for the growth of helper T
lymphocytes . To understand their mechanism of action, we are testing whether
lymphocyte-activating factors like IL-1 replace the function of DC, and whether
DC release these factors . In this paper, we have compared the effects ofDC with
exogenous murine rIL-la, which was the first activating factor to become
available in substantial quantity and purity . Elsewhere we will describe our
Distribution ofDC at 24 h Proliferation (cpm X 10-s Culture conditions* (specific activity and percent [sH]TdR)§
Exp . recovery)*
Initial IL-1 pulse Clusters Nonclusters Clusters Non- Mix DC/T ratio ofDC clusters
1 1:300 No 0.7(46) 0.08 (54) 1 .3 0.4 1 .9
1 :300 Yes 1 .7(82) 0.04 (18) 11 .7 0.5 14.6
1:100 No 2 .3(33) 0.32 (67) 10 .5 0.6 19 .4
1 :100 Yes 4 .8(65) 0.23 (35) 59 .0 1 .0 87 .2
2 1:300 No 1 .9(61) 0.06 (39) 11 .9 0.3 16 .1
1 :300 Yes 3.6(71) 0.06 (29) 35.4 0.4 63 .8
1:100 No 7 .1(49) 0.28 (51) 69.8 0.4 88 .2
1 :100 Yes 9.5(57) 0.33 (43) 97 .0 0.5 101 .5KOIDE ET AL .
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experiments showing that DC do not produce endogenous IL-1 when stimulated
with such agents as LPS (Koide, S . L . and R . M . Steinman, manuscript submitted
for publication) .
Using several populations of peripheral T cells and mitogenesis assays, we
cannot find support for the idea that IL-1 can mimic the function of DC .
Exogenous IL-1 does not directly influence the proliferation of isolated T cells
in mitogen or MLR systems (Tables I and II), and does not synergize with
mitogen or with antigen (Table III and Fig. 2) . In contrast, small doses of DC
are markedly stimulatory . When neutralizing antibodies to IL-1 are available, it
will be important to test whether these antibodies interfere with DC function .
However, the view that active accessory cells like DC are simply a source of
antigen plus IL-1 does not seem to be correct . There may yet be subsets ofT
cells that directly use IL-1 during lymphocyte growth . The D101ine that provides
a sensitive IL-1 bioassay is an example of aT cell that seems to grow in response
to IL-1 but not to DC (Fig . 5) .
While exogenous IL-1 does not act as a lymphocyte-activating factor, we have
discovered that low concentrations (plateau of 50 pM) significantly amplify
responses to limiting doses of DC (Tables III-V ; Fig. 3) . The enhancing effect
can be reproduced if the DC but not the T cells are exposed to the cytokine
before use as accessory cells (Table VI ; Figs . 3-5) . The phenomenon seems to
be specific for IL-1 rather than other cytokines, including cachectin/TNF, which
shares several functional properties with IL-1 (31) . It seems unlikely that lipo-
polysaccharide-induced release ofendogenous IL-1 might contribute to the basal
stimulatory function of DC . We have observed normal levels of DC function in
two experiments with LPS-unresponsive, C3H/Hej mice . Also we typically do
not find endogenous IL-1 production in spleen adherent cells (Koide and
Steinman, manuscript submitted for publication) .
Our studies of mechanism indicate that IL-1 must be applied to the DC for
some 18 h for maximal effect, and that there is no carryover of active IL-1 into
the culture (Fig . 5) . Nor does IL-1 increase the level of la on DC (Fig. 6) . The
one alteration in DC function that we can pinpoint is the more efficient clustering
of IL-1 treated DC with T cells before the onset of mitogenesis (Fig . 6, Table
VII) . Once clustered, control and IL-1-treated DC seem equally efficient in
inducing a proliferative response . IL-1 is the first molecule to be identified that
enhances immunity by enhancing DC function .
Summary
The function of exogenous murine recombinant IL-1« as a T lymphocyte-
activating molecule was examined . IL-1 did not induce IL-2 release or respon-
siveness in purified T cells regardless of their state of activation : unprimed
lymphocytes, freshly sensitized lymphocytes, or memory cells derived from the
blasts. Nor did IL-1 synergize with mitogens, or with antigens, to stimulate
proliferation . For example the combinations of IL-1 plus Ia+ peritoneal macro-
phages, or IL-1 plus Con A, were <5% as effective in triggering T cell growth
as a low dose (1 %) of dendritic cells . However, when IL-1 was added at the onset
of culture, the response to limiting doses of dendritic cells was increased 3- to
10-fold in several systems : the syngeneic and allogeneic MLR, Con A- and52 8
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periodate-induced polyclonal mitogenesis, and T-dependent antibody formation
against foreign red cells .
The amplifying effect of IL-I could be obtained if the dendritic cells but not
the responding lymphocytes were exposed to IL-1 before use as accessory cells .
Optimal activation of dendritic cells required a dose of 5 U/ml (50 pM) and 18
h of exposure, and was not due to carryover of IL-1 into the lymphocyte culture .
IL-2, IL-3, and cachectin/TNF did not amplify dendritic cell function, while
IFN-y diminished it . The enhanced function of IL-1-treated dendritic cells was
due to an enhanced clustering with helper T lymphocytes in the first day of the
MLR response .
Therefore IL-1 does not seem to act as an activating factor for most peripheral
T lymphocytes. Instead, IL-1 enhances the function of accessory dendritic cells
and represents the first molecule that has been shown to enhance the immune
response at this critical level .
The authors acknowledge the essential contributions of Drs . P . LoMedico (rIL-1), C .
Janeway (D10 cell line), J . Valinsky (FRCS analysis), and P . Freudenthal (carbocyanine
labeling of DC) .
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